-
EDITORIAL
A new era for EMA and for the US fiscal environment A content revolution for Pharma Horizon
C. Buonamico
-
COVER STORY
Grifols Partnership: The right fit for your premixed solutions
-
LATEST NEWS
EMA relocation: a case of politics and technical dossiers
C. Buonamico
-
COLUMN: INTELLECTUAL PROPERTY
The claims in the pharmaceutical patent – Peculiarities and exceptions
G. Tagliafico, S. Venturini
-
A WORD WITH
Vítor Sousa – Senior Manager, R&D Biological Division, Cerbios-Pharma SA, Cerbios
-
COLUMN: COMPLIANCE
New MedTech rules on educational events for healthcare professionals
D. Santoro, A. R. Carnà
-
COLUMN: MERGERS AND ACQUISITIONS
Life science M&As in Q4 of 2017: notes and trends
P. Souza
-
A WORD WITH
Dr. Pietro Allegrini – R&D Director and Dr. Stefano Togni – BD & Licensing Director, Indena
-
PANEL DISCUSSION
Oral Solid Dosage Manufacturing Process
-
COMPANY PROFILE
The PolyPeptide Group
-
SUPPLY CHAIN
Towards a new approach to modelling pharmaceutical supply chains in a changing technological landscape
E. Settanni, J. S. Stai
-
A WORD WITH
Enrico Zodio – Chief Executive Officer, Procos
-
SUPPLY CHAIN
Leveraging serialization to create a smarter supply chain
K. Franz, M. Howe
-
CONTRACT RESEARCH
Working with drug innovators to safely handle potent compounds: Navigating GHS classification and occupational health categorization in the workplace
E. M. Vancza, R. G. Sussman
-
CONTRACT MANUFACTURING
Flow chemistry as an enabling technology for essential medicine
M. M. Bio
-
SUPPLY CHAIN
Enterprise serialization Lessons learned from concept to execution
J. Schroeder
-
SUPPLY CHAIN
The right digital initiatives can turn your serialization investment into real ROI
E. Ozkaya
-
MARKETPLACE
Pharma industry outlook in 2018 What will be the key trends shaping the pharmaceutical industry in 2018? DCAT Value Chain Insights takes an inside look
P. V. Arnum
-
EVENTS
-
SCIENCE PIONEERS
Marie Curie: A science heroine in war and peace
M. Milano
-
INDUSTRY 4.0
Do I really need to become 4.0?
J. J. Alba
-
COLUMN: LIFE SCIENCES 4.0
4.0: a revolution wave for pharma industry and consumer/patient
A. Augeri
-
COLUMN: IN & OUT
-
BUSINESS NEWS
Click here to read the e-version of Vol. 2(1), January/February
Recent Posts
- SILAB – Skin immunity in the spotlight to celebrate 40 years of innovation
- IMERYS – Make-up bar silver award winner
- SYMRISE – Symrise launches Savelite® HB, a highly versatile multifunctional ingredient for protect
- HELIOSCREEN – Change of identity – HelioScreen becomes WENEOS
- An hereditary liver disease cured with the help of gene scissors
